Disease Categories Offered

GCR's groundbreaking cardiology platform harnesses the insights of whole genome sequencing to illuminate the genetic underpinnings of heart disease and pave the way for personalized, precision medicine.

With over 30 distinct types of heart disease, each with its unique subtypes, understanding the genetic factors that contribute to these conditions has long been a formidable challenge. However, GCR's cardiology platform overcomes this complexity, employing its proprietary rapid Whole Genome Insights technology™ to rapidly decode the entire genetic landscape of an individual.

This comprehensive approach empowers healthcare providers to make informed decisions, enabling early diagnosis, personalized risk assessment, and targeted treatment strategies. By identifying genetic mutations and variations associated with various cardiovascular conditions, GCR's cardiology platform empowers clinicians to tailor interventions to each patient's unique genetic profile.

GCR's cardiology platform represents a paradigm shift by early detection of heart disease, before symptoms arise, allows for timely intervention and prevention of complications. Personalized risk assessment empowers individuals to make informed lifestyle choices and proactively manage their health. And targeted treatment strategies, guided by an understanding of an individual's genetic susceptibility, can lead to more effective and individualized care.

Therapeutics

Navigating the Therapeutic Landscape

Empower your treatment decisions with a comprehensive guide to FDA-approved targeted therapies based on genomic biomarkers.

Key Points

  • Uncover personalized treatment options tailored to your unique genetic profile.
  • Explore the latest FDA-approved therapies backed by robust clinical evidence.
  • Gain insights into the science behind genomic biomarkers and their impact on treatment response.
  • Navigate the complex therapeutic landscape with confidence and informed decision-making.

Pharmacogenomics

Embrace Personalized Therapeutics: Tailored Treatment for a Healthier You

Our cutting-edge precision medicine platform harnesses the power of genetic information to revolutionize healthcare. By analyzing your unique genetic makeup, we can provide personalized treatment plans that are safer, more effective, and tailored to your individual needs.

Key Benefits

  • Prevent Over-dosing and Under-dosing: Accurately determine the most effective drug dosages based on your genetics, minimizing side effects and maximizing treatment outcomes.
  • Personalized Treatment Plans: Identify the most effective drugs for your specific genetic makeup, ensuring optimal treatment efficacy and reducing adverse reactions.
  • Empowering Patients: Make informed healthcare decisions guided by genetic insights, taking charge of your health for a brighter future.

Prevalence

Cardiovascular disorders (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. More than four out of five CVD deaths are due to heart attacks and strokes, and one-third of these deaths occur prematurely in people under 70 years of age.

The prevalence of CVDs varies widely by region. In 2019, the CVD death rate was highest in the Central Europe, Eastern Europe, and Central Asia region, at 444 deaths per 100,000 people. The lowest CVD death rate was in the Western Pacific region, at 221 deaths per 100,000 people.

Covered Disease Types and Sub-Types

  • Brugada Syndrome 1

  • Dilated Cardiomyopathy 1A
  • Dilated Cardiomyopathy 1G

  • Familial Hypercholesterolemia 1
  • Familial Hypercholesterolemia 3
  • Familial Hypercholesterolemia 4
  • Familial Hypercholesterolemia B

  • Familial Hypertrophic Cardiomyopathy 1
  • Familial Hypertrophic Cardiomyopathy 2
  • Familial Hypertrophic Cardiomyopathy 3
  • Familial Hypertrophic Cardiomyopathy 4
  • Familial Hypertrophic Cardiomyopathy 6
  • Familial Hypertrophic Cardiomyopathy 7
  • Familial Hypertrophic Cardiomyopathy 8
  • Familial Hypertrophic Cardiomyopathy 10
  • Familial Hypertrophic Cardiomyopathy 11

  • Familial Thoracic Aortic Aneurysm Type 2
  • Familial Thoracic Aortic Aneurysm Type 4
  • Familial Thoracic Aortic Aneurysm Type 6
  • Familial Thoracic Aortic Aneurysm Type 7
  • Familial Thoracic Aortic Aneurysm Type 8
  • Familial Thoracic Aortic Aneurysm Type 9
  • Familial Thoracic Aortic Aneurysm Type 10

  • Left Ventricular NonCompaction 6

  • Loeys-Dietz Syndrome 2

  • Short QT Syndrome Type 1
  • Short QT Syndrome Type 2
  • Short QT Syndrome Type 3